TheEdgeResearch
Home / Stocks / WILYY

Demant A/S (WILYY)

OTC Healthcare Medical - Devices
$25.71 ▲ +0.00%
Market Cap
$10.84B
Sector
Healthcare
Industry
Medical - Devices
Beta
0.75
52-Wk Range
13.45-29.41
CEO
Søren Nielsen
Country
DK
Currency
USD

Demant A/S operates in the Medical - Devices industry of the Healthcare sector, headquartered in Smørum, ZE, DK. The stock last traded at $25.71, up 0.00% on the session, giving a market capitalisation of $10.84B. On trailing twelve-month figures it carries a trailing P/E of 44.77, a net margin of 6.5%. Its beta of 0.75 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
44.77
Price / Sales
2.94
Price / Book
6.41
EV / EBITDA
16.23
Gross margin
71.0%
Operating margin
17.9%
Net margin
6.5%
Return on equity
—
Debt / equity
1.80
Current ratio
0.82
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
26,704
IPO date
2011-06-24
Headquarters
Smørum, ZE, DK
About Demant A/S

Demant A/S operates as a prominent international entity within the hearing health and audio technology sectors, extending its reach across Europe, North America, the Pacific region, and Asia. The company's activities are structured into two core divisions: Hearing Healthcare and Communications. The Hearing Healthcare segment focuses on the development, sale, and support of hearing aids, in addition to offering a range of diagnostic tools and associated services. Conversely, the Communications segment delivers headsets for professional contact centers, general office environments, and the gaming industry, all distributed under the EPOS brand. Established in 1904, Demant A/S, which was formerly known as William Demant Holding A/S until its name change in March 2019, maintains its corporate headquarters in Smørum, Denmark.

Comparable companies

Demant A/S is most often compared with the following Healthcare names:

AXILCHEOYCOCHGNNDYHRALINNDSONVY
More research on WILYY
WILYY technical analysis WILYY TheEdge Score Compare against peers
Open full interactive analysis & DCF →